Exact Mass: 366.0342

Exact Mass Matches: 366.0342

Found 33 metabolites which its exact mass value is equals to given mass value 366.0342, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Fructose citrate

3,4,5,6,10-pentahydroxy-3-(hydroxymethyl)-2,7,13,14-tetraoxatricyclo[8.3.2.0^{1,6}]pentadecane-8,12,15-trione

C12H14O13 (366.0434)


   

Glucose citrate

1,5,8,9,10-pentahydroxy-7-(hydroxymethyl)-4,6,11,15-tetraoxatricyclo[7.3.3.0^{5,10}]pentadecane-3,12,14-trione

C12H14O13 (366.0434)


   

2-(3,4-Dicarboxy-3-hydroxybutanoyl)oxypropane-1,2,3-tricarboxylic acid

2-[(3,4-dicarboxy-3-hydroxybutanoyl)oxy]propane-1,2,3-tricarboxylic acid

C12H14O13 (366.0434)


   

2-(3,4-Dicarboxy-2-hydroxybutanoyl)oxypropane-1,2,3-tricarboxylic acid

2-[(3,4-dicarboxy-2-hydroxybutanoyl)oxy]propane-1,2,3-tricarboxylic acid

C12H14O13 (366.0434)


   
   

cassiapyrone-10-sulphate

cassiapyrone-10-sulphate

C16H14O8S (366.0409)


   
   

3-Bromo-4-hydroxy-alpha-(hydroxyimino)-N-[2-(1H-imidazol-4-yl)ethyl]benzenepropanamide

3-Bromo-4-hydroxy-alpha-(hydroxyimino)-N-[2-(1H-imidazol-4-yl)ethyl]benzenepropanamide

C14H15BrN4O3 (366.0327)


   

Calcium phenylpyruvate

Calcium phenylpyruvate

C18H14CaO6 (366.0416)


   

Benzenesulfonic acid,4-hydroxy-3-[2-(2-hydroxy-1-naphthalenyl)diazenyl]-, sodium salt (1:1)

Benzenesulfonic acid,4-hydroxy-3-[2-(2-hydroxy-1-naphthalenyl)diazenyl]-, sodium salt (1:1)

C16H11N2NaO5S (366.0286)


   

2-(2-BROMO-5-(TRIFLUOROMETHOXY)PHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE

2-(2-BROMO-5-(TRIFLUOROMETHOXY)PHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE

C13H15BBrF3O3 (366.025)


   

Magnesium 1,1,1-trifluoro-2,4-pentanedionate 2-hydrate

Magnesium 1,1,1-trifluoro-2,4-pentanedionate 2-hydrate

C10H12F6MgO6 (366.0389)


   

phenylpyruvic acid calcium salt

phenylpyruvic acid calcium salt

C18H14CaO6 (366.0416)


   

4,4,5,5,6,6,7,7,7-nonafluoro-1-phenylheptane-1,3-dione

4,4,5,5,6,6,7,7,7-nonafluoro-1-phenylheptane-1,3-dione

C13H7F9O2 (366.0302)


   

1,2,3,4,5,6-CYCLOHEXANEHEXACARBOXYLIC ACID MONOHYDRATE

1,2,3,4,5,6-CYCLOHEXANEHEXACARBOXYLIC ACID MONOHYDRATE

C12H14O13 (366.0434)


   
   

Pifithrin-α hydrobromide

Pifithrin-α hydrobromide

C16H19BrN2OS (366.0401)


Pifithrin-α hydrobromide is a p53 inhibitor which blocks its transcriptional activity and prevents cells from apoptosis. Pifithrin-α hydrobromide is also an aryl hydrocarbon receptor (AhR) agonist.

   

(5aR,6S)-6-methoxy-6-[[(thiophen-2-yl)acetyl]amino]-5a,6-dihydro-3H,7Hazeto[ 2,1-b]furo[3,4-d][1,3]thiazine-1,7(4H)-dione (cefoxitin lactone)

(5aR,6S)-6-methoxy-6-[[(thiophen-2-yl)acetyl]amino]-5a,6-dihydro-3H,7Hazeto[ 2,1-b]furo[3,4-d][1,3]thiazine-1,7(4H)-dione (cefoxitin lactone)

C15H14N2O5S2 (366.0344)


   

1 2 3 4 5 6-CYCLOHEXANEHEXACARBOXYLIC A&

1 2 3 4 5 6-CYCLOHEXANEHEXACARBOXYLIC A&

C12H14O13 (366.0434)


   

2-[(5,6-dimethyl-4-oxo-3H-thieno[2,3-d]pyrimidin-2-yl)thio]-N-(4-methyl-2-thiazolyl)acetamide

2-[(5,6-dimethyl-4-oxo-3H-thieno[2,3-d]pyrimidin-2-yl)thio]-N-(4-methyl-2-thiazolyl)acetamide

C14H14N4O2S3 (366.0279)


   

1,5,8,9,10-Pentahydroxy-7-(hydroxymethyl)-4,6,11,15-tetraoxatricyclo[7.3.3.05,10]pentadecane-3,12,14-trione

1,5,8,9,10-Pentahydroxy-7-(hydroxymethyl)-4,6,11,15-tetraoxatricyclo[7.3.3.05,10]pentadecane-3,12,14-trione

C12H14O13 (366.0434)


   

3,4,5,6,10-Pentahydroxy-3-(hydroxymethyl)-2,7,13,14-tetraoxatricyclo[8.3.2.01,6]pentadecane-8,12,15-trione

3,4,5,6,10-Pentahydroxy-3-(hydroxymethyl)-2,7,13,14-tetraoxatricyclo[8.3.2.01,6]pentadecane-8,12,15-trione

C12H14O13 (366.0434)


   

6-chloro-N-(3,4-dimethylphenyl)-3-oxo-4H-1,4-benzoxazine-7-sulfonamide

6-chloro-N-(3,4-dimethylphenyl)-3-oxo-4H-1,4-benzoxazine-7-sulfonamide

C16H15ClN2O4S (366.0441)


   

2-chloro-N-[3-(2-thiazolo[5,4-b]pyridinyl)phenyl]-3-pyridinecarboxamide

2-chloro-N-[3-(2-thiazolo[5,4-b]pyridinyl)phenyl]-3-pyridinecarboxamide

C18H11ClN4OS (366.0342)


   

5-(2-Benzofuranyl)-4-[(1-methyl-5-tetrazolyl)thio]thieno[2,3-d]pyrimidine

5-(2-Benzofuranyl)-4-[(1-methyl-5-tetrazolyl)thio]thieno[2,3-d]pyrimidine

C16H10N6OS2 (366.0357)


   

Phosphoric acid (1,1-dioxo-2,3-dihydrothiophen-3-yl) diphenyl ester

Phosphoric acid (1,1-dioxo-2,3-dihydrothiophen-3-yl) diphenyl ester

C16H15O6PS (366.0327)


   

[6-hydroxy-3-[(Z)-3-(3-hydroxyphenyl)-3-oxoprop-1-enyl]-2-methoxyphenyl] hydrogen sulate

[6-hydroxy-3-[(Z)-3-(3-hydroxyphenyl)-3-oxoprop-1-enyl]-2-methoxyphenyl] hydrogen sulate

C16H14O8S (366.0409)


   

[4-(7-Hydroxy-8-methoxy-4-oxo-2,3-dihydrochromen-2-yl)phenyl] hydrogen sulate

[4-(7-Hydroxy-8-methoxy-4-oxo-2,3-dihydrochromen-2-yl)phenyl] hydrogen sulate

C16H14O8S (366.0409)


   

1,1,3,3-Tetramethyl-1,3-bis(trimethylsilyl)digermoxane

1,1,3,3-Tetramethyl-1,3-bis(trimethylsilyl)digermoxane

C10H30Ge2OSi2 (366.0277)


   

5-bromo-3-(5-hydroxy-2-imino-1,3-dimethylimidazolidin-4-yl)-1h-indole-2-carboxylic acid

5-bromo-3-(5-hydroxy-2-imino-1,3-dimethylimidazolidin-4-yl)-1h-indole-2-carboxylic acid

C14H15BrN4O3 (366.0327)


   

5-bromo-3-[(4s,5r)-5-hydroxy-2-imino-1,3-dimethylimidazolidin-4-yl]-1h-indole-2-carboxylic acid

5-bromo-3-[(4s,5r)-5-hydroxy-2-imino-1,3-dimethylimidazolidin-4-yl]-1h-indole-2-carboxylic acid

C14H15BrN4O3 (366.0327)


   

3-(3-bromo-4-hydroxyphenyl)-2-(n-hydroxyimino)-n-[2-(3h-imidazol-4-yl)ethyl]propanamide

3-(3-bromo-4-hydroxyphenyl)-2-(n-hydroxyimino)-n-[2-(3h-imidazol-4-yl)ethyl]propanamide

C14H15BrN4O3 (366.0327)


   

(2e)-3-(3-bromo-4-hydroxyphenyl)-2-(n-hydroxyimino)-n-[2-(3h-imidazol-4-yl)ethyl]propanimidic acid

(2e)-3-(3-bromo-4-hydroxyphenyl)-2-(n-hydroxyimino)-n-[2-(3h-imidazol-4-yl)ethyl]propanimidic acid

C14H15BrN4O3 (366.0327)